Read about research updates presented at MDS 2024 Every year, the International Parkinson and Movement Disorder Society (MDS) holds its International Congress of Parkinsonโs Disease and Movement Disorders (also known as the MDS Congress), which is the preeminent gathering of medical professionals from around the world who are dedicated to researching and treating Parkinsonโs disease […]
How carbidopa/levodopa is used to treat Parkinsonโs disease symptoms Loss of neurons in the brain that use dopamine to communicate is one of the hallmark features of Parkinsonโs disease (PD), causing slowness, stiffness, tremor, and balance problems. Replacing the brainโs dopamine is therefore one of the key treatment strategies to help improve the motor symptoms […]
The Parkinson’s Disease Medication Pipeline The pipeline for Parkinsonโs disease (PD) medications is extremely crowded these days, with multiple medications at various stages of research development. This is very exciting news for the PD community and is a perfect example of the โhope in progressโ part of our organizationโs motto. It is thrilling to see […]
How many people have Parkinsonโs disease? You may have heard the statistic that there are approximately one million people with Parkinsonโs disease (PD) living in the US. That means approximately 1 out of every 336 people are living with PD. That number has increased in past decades and will continue to increase. ย With a new […]
Exciting New Parkinsonโs Disease Research is Underway On September 5, 2024, APDA announced 20 new Parkinsonโs disease (PD) research grants, for a total of $ 2.6 million in funding for the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinsonโs disease (PD) and to develop new treatments and eventually, a […]
It has long been understood that Parkinsonโs disease (PD) does not just cause movement, or motor, symptoms, but also causes a litany of non-motor symptoms with effects throughout the body. One of the organ systems that is affected is the cardiac system, encompassing the heart, as well as the major and minor blood vessels.
DaTscan: A test to help in the diagnosis of Parkinson’s What is a DaTscan and how is it performed? In 2011, the Food and Drug Administration (FDA) approved an imaging test to help diagnose Parkinson’s disease (PD) called DaTscan (dopamine transporter scan). In this test, a radioactive tracer, Ioflupane (123I), also known as DaTscan, is injected […]
What is gene therapy and can it help people with Parkinsonโs? You may have read about efforts to use gene therapy as a treatment for Parkinsonโs disease (PD). Itโs an exciting prospect and studies are underway, with some positive results so far. Understanding these studies and therapies requires some background information about what genes are […]
Dr. Gilbert gives an update on stem cell therapies for the treatment of Parkinsonโs, including profiling a few notable clinical trials underway in 2024
Understanding Cognitive Challenges in Parkinsonโs Disease: PDD vs. DLB Cognitive challenges are a very common non-motor symptom of Parkinsonโs disease (PD). When the cognitive challenges are severe enough to interfere with daily activity, they are known as Parkinsonโs disease dementia (PDD). You may have heard of another condition called Dementia with Lewy Bodies (DLB). Although […]
Simple Email Signup v2 (Salsa replacement form)
